微芯片毛细管电泳非接触电导法快速测定盐酸倍他洛尔

建立了微芯片毛细管电泳非接触电导检测法快速测定盐酸倍他洛尔滴眼液中盐酸倍他洛尔的含量。探讨了缓冲液类型、浓度、分离电压及进样时间等因素对分离检测的影响。实验采用1.5 mmol·L-1HAc-1.5mmol·L-1Na Ac(p H=4.69)为缓冲溶液,分离电压为2.1 k V,进样时间10.0 s。此条件下于0.7 min内实现了盐酸倍他洛尔的快速分离测定。盐酸倍他洛尔的浓度在5.0~200.0μg·m L-1线性良好(r=0.9997,n=6),检出限为1.0μg·m L-1(S/N=3),RSD为0.8%,样品的加标回收率为100.4%~102.0%。滴眼液中的辅料在该条件下不干扰测定,可成功测定盐酸倍他洛尔滴眼液中盐酸倍他洛尔的含量。     

微流控芯片非接触电导法快速测定盐酸美金刚片中盐酸美金刚的含量

建立了微流控芯片非接触电导法快速测定盐酸美金刚片中盐酸美金刚含量的方法。探讨了缓冲溶液的种类、浓度、pH值、进样时间及分离电压等因素对分离检测的影响。优化得到缓冲体系为含2%(体积分数)二甲基亚砜(DMSO)的3.0 mmol/L三乙胺-2.0 mmol/L磷酸缓冲溶液(pH 3.3),进样时间为10 s,分离电压为2.0 kV。优化条件下,盐酸美金刚的线性范围为10～2 000μg/mL(r~2=0.999 1);检出限为7μg/mL,定量下限为10μg/mL;精密度、稳定性、重复性实验的相对标准偏差(RSD)均小于2.0%;平均加标回收率为96.5%～99.2%;盐酸美金刚的检测时间小于18 s。该方法快速简便,适用于盐酸美金刚片中盐酸美金刚含量的测定。     

微流控芯片快速测定乌龙茶中盐酸氯胺酮的含量

建立了微流控芯片非接触电导检测法快速测定盐酸氯胺酮含量的方法。探讨了缓冲液类型和浓度、分离电压、进样时间等因素对分离检测的影响。采用8.0 mmol·L~(-1)醋酸-7.0 mmol·L~(-1)醋酸钠(pH=4.87)为缓冲溶液,分离电压2.0 kV,进样时间15.0 s,在2.5 min内实现了盐酸氯胺酮的快速分离测定。实验表明,在5.0~100.0μg·mL~(-1)范围内,盐酸氯胺酮的峰面积与其浓度呈良好的线性关系,检出限为3.0μg·mL~(-1)(S/N=3),RSD为0.18%,加标回收率为95.7%~103.7%。该法快速简便,可用于乌龙茶中盐酸氯胺酮的快速分离检测。     

微芯片毛细管电泳快速测定盐酸洛美沙星

采用微芯片毛细管电泳非接触电导检测法快速测定了盐酸洛美沙星胶囊中盐酸洛美沙星的含量。探讨了缓冲液类型、浓度,添加剂种类、浓度及分离电压、进样时间等因素对分离检测的影响。实验采用5.0mmol/L HAc(pH=2.5)+5%乙醇为缓冲溶液,分离电压3.0 kV,在1 min内实现了盐酸洛美沙星的快速分离测定。优化条件下盐酸洛美沙星的线性范围为20.0～250.0μg/mL,检出限为10.0μg/mL(S/N=3),RSD=2.0%,加标回收率为98.6%～103%。     

药物中盐酸异丙嗪的微流控芯片非接触电导法快速检测

建立了微流控芯片非接触式电导法快速测定药物中盐酸异丙嗪含量的分析方法.研究了缓冲液、添加剂、分离电压和进样时间等因素对检测的影响,以20 mmol·L-1 MES-20 mmol·L-1 His 的缓冲液为分离介质,分离电压为2.2 kV时可实现较好的分离检测.在优化实验条件下,盐酸异丙嗪的线性范围为100 ～1 000 mg·L-1;检出限(S/N=3)为10 mg·L-1;线性方程为Y＝-502+4.99×103X,相关系数r=0.995 6;0.1 g·L-1盐酸异丙嗪的RSD为2.1%(n＝5);3批药品的加标回收率为96% ～101%,RSD为1.7% ～3.0%.该方法简便、快速、灵敏度高,可以用于盐酸异丙嗪药物的质量控制.     

微流控芯片对盐酸利多卡因注射液中盐酸利多卡因的测定

建立了微流控芯片非接触电导检测法测定盐酸利多卡因注射液中盐酸利多卡因含量的方法。探讨了缓冲液种类和浓度、添加剂种类和浓度、分离电压和进样时间等因素对分离检测的影响。优化并选择1.0mmol/L HAc-2.0 mmol/L NaAc(pH 4.5)为缓冲溶液,1%乙醇为添加剂,分离电压为2.4 kV,进样时间为10 s,2 min内可实现盐酸利多卡因的快速检测。在优化实验条件下,盐酸利多卡因的线性范围为20~250mg/L(r=0.996),检出限(S/N=3)可达5.0 mg/L,RSD为1.7%,加标回收率为97%~99%。方法简便快速、重复性好,适用于药品生产的质量控制。     

高效毛细管电泳-电化学检测滴鼻液中盐酸麻黄碱和磺胺嘧啶

采用毛细管电泳-电化学检测法(CE-ED) 同时测定滴鼻液中盐酸麻黄碱和磺胺嘧啶的含量,考察了缓冲液酸度和浓度、氧化电位、分离电压和进样时间等试验参数对分离检测的影响.在最佳试验条件下,工作电极为直径 300 μm 的碳圆盘电极,检测电位为 0.95 V(vs.SCE),缓冲液为50 mmol·L-1 硼砂-硼酸溶液(pH 8.0),分离电压为 17 kV,上述两组分在 7 min 内即可实现分离.盐酸麻黄碱和磺胺嘧啶在三个数量级的范围内呈线性,检出限(S/N=3)分别为 7.0×10-5g·L-1和3.0×10-5g·L-1,回收率在 97.0%～98.0%之间.     

微流控芯片非接触电导检测法测定药片中盐酸奈福泮

建立了微流控芯片非接触电导检测法测定片剂中盐酸奈福泮含量的方法.探讨并优化了缓冲溶液种类和配比、添加剂、分离电压和进样时间等电泳分离条件.结果表明,以2mmol/L HAc+1mmol/L NaAc( pH4.5)不加添加剂为运行缓冲溶液,分离电压2.00 kV、进样时间10 s时,1min内可实现盐酸奈福泮快速分离检...     

联吡啶钌体系电化学发光法测定克林霉素的研究

建立了以金电极为工作电极电致化学发光测定盐酸克林霉素的方法,并采用循环伏安和电致化学发光法,研究了体系的电化学行为和电化学发光行为.研究结果表明,在0.1 mol/L的硼酸(pH 8.0)缓冲溶液中,扫描速率为100 mV/s时,ECL的峰高与盐酸克林霉素浓度在1.0×10-5 ～1.0×10-4 mol/L和1.0×10-7 ～8.0×10-6 mol/L范围内呈线性关系,其线性回归方程分别为I(counts)=465.00×105c-133.80(r=0.996 8)和I(counts)=20.333×106c+100.25(r=0.995 9).方法的检出限为1.0×10-7 mol/L(S/N=3).连续测定2.0×10-5 mol/L的盐酸克林霉素溶液10次,发光强度值的RSD为1.74%.对样品进行加标回收率实验,回收率为93% ～102%.该方法具有较高的选择性和灵敏度,样品处理简单快速,用于盐酸克林霉素胶囊的测定,结果满意.     

微流控芯片非接触电导法测定注射液中的门冬氨酸鸟氨酸

建立了微流控芯片非接触电导检测法快速分离检测门冬氨酸鸟氨酸注射液中门冬氨酸鸟氨酸的分析方法。考察了缓冲溶液的种类和浓度、添加剂、进样时间、分离电压等因素对分离检测的影响。在优化条件下,即以4 mmol/L M ES-6 mmol/L(L)-His(p H 4.5)为缓冲溶液,分离电压2.00 k V、进样时间10 s,1 min内可实现较好的分离和检测,门冬氨酸鸟氨酸的线性范围为20~200μg/m L,相关系数为0.9990,检出限(S/N=3)为10.0μg/m L,RSD为1.9%,加标回收率为97.6%~101.3%。方法可用于门冬氨酸鸟氨酸的质量控制。     

Simple method for the assay of clindamycin in human plasma by reversed-phase high-performance liquid chromatography with UV detector

A rapid and simple high-performance liquid chromatography (HPLC) method was developed and validated for the quantification of clindamycin in human plasma. After precipitation with 50% trichloroacetic acid (TCA) containing the internal standard, propranolol, the analysis of the clindamycin level in the plasma samples was carried out using a reverse-phase cyano (CN) column with ultraviolet detection (204 nm). The chromatographic separation was accomplished with an isocratic mobile phase consisting of acetonitrile-distilled water-7.6 mm tetramethylammonium chloride (TMA) (60:40:0.075, v/v/v), adjusted to pH 3.2. The proposed method was specific and sensitive with a lower limit of quantitation (LLOQ) of 0.2 microg/mL. This HPLC method was validated by examining the precision and accuracy for inter- and intraday analysis in the concentration range 0.2-20.0 microg/mL. The relative standard deviations (RSD) in the inter- and intraday validation were 6.1-14.9 and 6.0-16.1%, respectively. In the stability test, clindamycin was found to be stable in human plasma during the storage and assay procedure. The present HPLC method was applied to the analysis of samples taken up to 12 h after a single oral administration of clindamycin in healthy volunteers.     

HPLC分析法在克林霉素磷酸酯合成工艺中的应用

采用高效液相色谱-内标法研究了克林霉素磷酸酯合成工艺的后处理过程.结果表明在克林霉素磷酸酯的浓缩过程中高温下会有少量分解,故应对浓缩温度及时间进行控制.     

Therapeutic Efficacy of Sesquiterpene Farnesol in Treatment of Cutibacterium acnes-Induced Dermal Disorders

Acne vulgaris is a highly prevalent skin disorder requiring treatment and management by dermatologists. Antibiotics such as clindamycin are commonly used to treat acne vulgaris. However, from both medical and public health perspectives, the development of alternative remedies has become essential due to the increase in antibiotic resistance. Topical therapy is useful as a single or combined treatment for mild and moderate acne and is often employed as maintenance therapy. Thus, the current study investigated the anti-inflammatory, antibacterial, and restorative effects of sesquiterpene farnesol on acne vulgaris induced by Cutibacterium acnes (C. acnes) in vitro and in a rat model. The minimum inhibitory concentration (MIC) of farnesol against C. acnes was 0.14 mM, and the IC₅₀ of 24 h exposure to farnesol in HaCaT keratinocytes was approximately 1.4 mM. Moreover, 0.8 mM farnesol exhibited the strongest effects in terms of the alleviation of inflammatory responses and abscesses and necrotic tissue repair in C. acnes-induced acne lesions; 0.4 mM farnesol and clindamycin gel also exerted similar actions after a two-time treatment. By contrast, nearly doubling the tissue repair scores, 0.4 mM farnesol displayed great anti-inflammatory and the strongest reparative actions after a four-time treatment, followed by 0.8 mM farnesol and a commercial gel. Approximately 2–10-fold decreases in interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, found by Western blot analysis, were predominantly consistent with the histopathological findings and tissue repair scores. The basal hydroxypropyl methylcellulose (HPMC) gel did not exert anti-inflammatory or reparative effects on rat acne lesions. Our results suggest that the topical application of a gel containing farnesol is a promising alternative remedy for acne vulgaris.     

钯（II）-克林霉素-卤代荧光素体系的共振瑞丽散射光谱及其分析应用

在pH为5.0-5.4的乙酸-乙酸钠缓冲溶液中,克林霉素（Clin）与钯(Ⅱ)形成螯合阳离子,它能进一步与二碘荧光素（DIF）,赤藓红（Ery）,曙红Y（EY）等卤代荧光素类染料反应形成1：1：1的三元离子缔合物,此时将引起吸收光谱变化和荧光猝灭,同时还导致共振瑞利散射(RRS)的急剧增强并产生新的RRS光谱,钯(Ⅱ)-克林霉素与DIF,Ery和EY形成产物的最大散射波长分别位于285,287,32 1nm处,另外还有些较弱的散射峰存在。散射增强（ΔI）与克林霉素浓度在一定范围内成正比,可用于克林霉素的定量测定。对于DIF,Ery和EY体系的线性范围和检出限分别为0.025-2.1μg•mL-1和7.8 ng•mL-1,0.053-2.4μg•mL-1和16.0 ng•mL-1;以及0.038-2.4μg•mL-1和11.0 ng•mL-1。本文研究了适宜的反应条件,考察了共存物质的影响,表明方法有较好的选择性,基于三元离子缔合物的RRS光谱,发展了一种高灵敏、简便快速测定克林霉素的新方法。文中还对离子缔合物的组成,结构和反应机理,以及离子缔合物对吸收,荧光和RRS光谱的影响进行了讨论。     

同步荧光测定法同时测定盐酸普萘洛尔和盐酸氟桂利嗪

提出了用同步荧光测定法同时测定盐酸普萘洛尔和盐酸氟桂利嗪。试验表明:荧光检测盐酸普萘洛尔的波长宜选定296nm、盐酸氟桂利嗪的波长宜选定263nm、波长差Δλ为50nm条件下进行同步扫描。盐酸普萘洛尔和盐酸氟桂利嗪的质量浓度分别在1.2×10-6～2.8×10-3g.L-1和2.0×10-5～3.6×10-3g.L-1范围内与荧光强度呈线性关系,检出限(3S/N)分别为3.2×10-7g.L-1和6.8×10-6g.L-1。方法用于混合样品中盐酸普萘洛尔与盐酸氟桂利嗪含量的同时测定,回收率在97.5%～101.1%和97.5%～101.7%之间。     

盐酸环丙沙星及其制剂含量测定方法的探讨

非水滴定法测定盐酸环丙沙星的含量时，需要预先加入冰乙酸和乙酸汞进行转化处理，两种试剂的加入顺序对盐酸环丙沙星的溶解速度影响较大，先加入乙酸汞时，盐酸环丙沙星溶解较快。用高效液相色谱法测定盐酸环丙沙星片及盐酸环丙沙星胶囊的含量时，如果以水作溶剂，测定值明显偏低，宜改用0.l mol／L盐酸溶液作溶剂。     

Application of an LC–ESI–QTOF–MS method for evaluating clindamycin concentrations in plasma and prostate microdialysate of rats

Clindamycin is used for infections caused by Gram-positive and Gram-negative anaerobic pathogens and Gram-positive aerobes. Propionibacterium acnes is an important opportunistic microorganism of the human skin and is related to prostatitis. An LC–electrospray ionization–quadrupole time-of-flight–MS method was validated for determining clindamycin concentrations in plasma and prostate microdialysate. Clindamycin separation was carried out on a C₁₈ column at 0.5 mL/min. The mobile phase employed gradient elution of formic acid and methanol. A mass spectrometer was operated in positive electrospray ionization mode to monitor ion 425.1784 and 253.1152 for clindamycin and cimetidine (internal standard), respectively. Linearity was obtained at 0.5–10.0 μg/mL (plasma) and 0.05–1.0 μg/mL (microdialysate) with coefficients of determination ≥0.999. The intra- and inter-day precision (coefficient of variation - CV%) values were ≤13.83% and 12.51% for plasma, respectively, and ≤10.90% and 9.35% for microdialysate, respectively. The accuracy was between 90.82% and 108.25% for plasma, and 96.97% and 106.98% for microdialysate. The present method was fully validated and applied to investigate clindamycin concentrations in both plasma and prostate by microdialysis in Wistar rats (80 mg/kg, intravenous). Because the penetration of antibiotics into the prostate may be restricted, this method allows us to investigate the prostate concentrations of clindamycin for the first time.     

电堆积柱上富集-高效毛细管电泳法测定药品中盐酸麻黄碱和盐酸伪麻黄碱的含量

应用电堆积柱上富集-高效毛细管电泳法测定了6种药品中盐酸麻黄碱和盐酸伪麻黄碱含量。试验选择了以下分析条件:①检测波长205 nm;②内标物为间苯二酚;③运行液为pH9.2的40 mmol·L-1硼砂缓冲溶液;④分离电压20 kV;⑤进样时间10 s;⑥分离温度25℃。麻黄碱及伪麻黄碱质量浓度在1~400 mg·L-1之间与相应的相对峰面积值(即被测物与内标物的峰面积之比)呈线性关系。方法的检出限(3S/N)为0.35 mg·L-1(麻黄碱)和0.29 mg·L-1(伪麻黄碱)。以2种药品作基体加入标准溶液做回收试验,测得平均回收率依次为101.1%及103.6%。     

高效液相色谱法测定林可霉素利多卡因凝胶中盐酸利多卡因含量

建立了高效液相色谱法（HPLC）测定林可霉素利多卡因凝胶中盐酸利多卡因含量的方法.优化后的试验条件如下：色谱柱为Agilent 5 Tc-C18（2）（250 mm×4.6 mm,5 μm）,流动相为0.05 mol/L硼砂溶液（pH=6.0）-甲醇-乙腈（体积比为68：19：13）,紫外检测波长为214 nm,流速1.0 mL/min,柱温30℃,进样量20 μL.试验结果表明：利多卡因的线性范围为40.1~240.6 μg/mL（r =0.999 4）,加样回收率为97.6%.建立的方法操作简便,可用于制剂中盐酸利多卡因的质量控制.